NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Drug Development


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
3M Licenses Vaccine Adjuvants to VaxInnate
2009 NOV 26 ... 3M Drug Delivery Systems has signed an agreement with VaxInnate Corporation under which ... increasing the effectiveness of vaccines," said Dr. Mark Tomai, PhD, Vaccine Business Development Director, 3M Drug Delivery Systems."The combination of VaxInnate's ...
Subject: 3M
Price: $3.00
*
Advances in malaria research show promise for fight against 1 of the world's deadliest diseases
2009 NOV 29 ... tools like insecticide treated bed nets and an effective anti-malarial combination drug based on artemisinin, has helped the fight."Malaria control and possible ... that triggers an immune response in multiple mosquito species capable of stopping the development of Plasmodium falciparum. By silencing the gene, caspar, the researchers were able to ...
Subject: Burness Communications
View Free
Daily News
Article
Endovascular Forum and GEST Set Out on a Shared Venture to Bring the Highest Level of Embolization-based Scientific and Technical Education, Results, and Relevance for Patient Care
2009 NOV 28 ... malformations is fully dependent on embolization techniques. Oncology treatment with drug-eluting and target-specific beads is another fast-growing field of embolization ... are excited to count GEST as our most recent partner in the further development of the Endovascular Forum's clinical exchange platform," said Rony Sellam, Chief ...
Subject: IC Sciences Corporation
Price: $3.00
*
Forget all about it: Traumatic memories can be erased
2009 NOV 29 ... Faculty Members for F1000, reports an extraordinary finding that supports the use of a drug to control recollections of traumatic incidents.The researchers demonstrated ... that ... control the stability of fear memories is extremely important for the development of new and better therapies for anxiety disorders".The article was also ...
Subject: Faculty of 1000: Biology and Medicine
View Free
Daily News
Article
HEI, Inc. Achieves AS9100B and ISO 9001:2008 Certification
2009 NOV 26 ... Division PO Box 5000, 1495 Steiger Lake Keywords: HEI, Inc., U.S. Food and Drug Administration, FDA This article was prepared by FDA Law Weekly editors ... industry. The AS9100 standard requires companies to have robust systems in design and development, process validation, process controls, vendor management and documentation. ...
Subject: HEI, Inc.
Price: $3.00
*
ICDC College Wins Coveted Approval as Institution of Higher Learning IHL by the Department of Veterans Affairs
2009 NOV 28 ... of the new GI bill, ICDC College has received tremendous interest in its Alcohol and Drug Counseling curricula and particularly for its industry-pioneering Homeland Security ... Aide, Pharmacy Technician, Computerized Accounting, Dental Technician, Graphic/Web Development, Massage Therapy, Business Officer Administrator, Alcohol and Drug Counseling, Homeland ...
Subject: ICDC College
Price: $3.00
*
Inhibitex Reports Third Quarter 2009 Financial Results
2009 NOV 28 ... of ongoing GLP studies, believe we are on track to file an investigational new drug application and initiate a Phase I clinical trial of INX-189 in the first half of ... make progress on all fronts, including the advancement of our differentiated antiviral development programs and most recently, the completion of a financing that we believe strategically ...
Subject: Inhibitex, Inc.
Price: $3.00
*
Local health investigation sheds light on gastroschisis birth defect
2009 NOV 28 ... as control-group mothers to report use of at least one vasoconstrictive recreational drug before pregnancy. Vasoconstrictive recreational drugs constrict blood vessels and ... such as pseudoephedrine; and some recreational drugs, may be contributing factors in the development of gastroschisis.In this study, "case mothers," mothers who had babies ...
Subject: University of Nevada, Reno
Price: $3.00
*
Locus Pharmaceuticals Announces Focus on Drug Discovery Collaboration Business, Branded as Ansaris
2009 NOV 26 ... collaboration projects with pharmaceutical partners, and built a pipeline of early drug development assets for cancer and inflammatory indications.Keywords: Health, ...
Subject: Locus Pharmaceuticals
Price: $3.00
*
November/December 2009 Annals of Family Medicine tip sheet
2009 NOV 29 ... Ecological, Ecology, Environment, Finance, Financial, Investing, Investment, Adverse Drug Effect, Adverse Drug Event, Adverse Drug Reaction, Antibacterial, Antibiotic, ... and family medicine residency. They conclude that a successful partnership relies on the development of a shared mission of education and service, as well as innovation and flexibility by ...
Subject: American Academy of Family Physicians
Price: $3.00
*
Pennsylvania's Impaired Driving Program Earns National Award
2009 NOV 28 ... technology implementation such as Ignition Interlock devices, and police training in drug recognition.There were 12,752 alcohol-related crashes in Pennsylvania during ... through infrastructure improvements, operational improvements or program planning, development and evaluation.PennDOT's impaired driving program utilizes a data-driven ...
Subject: Pennsylvania Department of Transportation
Price: $3.00
*
Recent findings from Cincinnati Children's Hospital, Medical Department highlight research in diet and nutrition
2009 NOV 25 ... Therapy, Treatment, Endocrinology, Estrogen, Hormones, Women's Health, Biotechnology, Drug Development, Alternative Medicine, Diet and Nutrition, Cincinnati Children's Hospital, Medical ...
Subject: Diet and Nutrition
Price: $3.00
*
Reports from Thomas Jefferson University advance knowledge in surgery
2009 NOV 25 ... Life Sciences, Blood Transfusion, Medical Device, Transfusion Medicine, Pharmaceuticals, Drug Development, Therapy, Treatment, Clopidogrel, Antiplatelet, Fibrinolytic Agent, Platelet Aggregation ...
Subject: Surgery
Price: $3.00
In Cart
Reports on pediatric immunology findings from F. Acquistapace and co-researchers provide new insights
2009 NOV 28 ... symptoms) to 3 (=severe symptoms) and the medication score (MS) evaluating symptomatic drug intake (antihystamine and inhaled corticosteroids). SS and MS were evaluated at the end ... the period of maximum allergen exposure in case of perennial AR). of the study was the development of asthma symptoms during the observation period. SS (mean +/- SD) was 4.5 +/- 2.5 in ...
Subject: Pediatric Immunology
Price: $3.00
In Cart
Reports outline medicinal chemistry study results from A. Putey et al
2009 NOV 27 ... Country:France, Life Sciences, Therapy, Treatment, Antiproliferative Activity, Drug Development, Medicinal Chemistry.This article was prepared by Chemicals & Chemistry ...
Subject: Medicinal Chemistry
Price: $3.00
*
Reports outline molecular pharmaceutics study findings from J.A. Reddy and colleagues
2009 NOV 25 ... favorably low toxicity profile." "In contrast, the natural tubulysin B drug proved to be inactive against a human nasopharyngeal tumor model when administered at ... those which are generally more chemoresistant, and that EC0305 should be considered for development as a candidate for the treatment of advanced FR-expressing human cancers." ...
Subject: Molecular Pharmaceutics
Price: $3.00
*
Right first time: Pioneering new methods of drug manufacture
2009 NOV 29 ... industrial partners.Keywords: Chemicals, Chemistry, Engineering, Technology, Drug Development, Pharmaceuticals, Therapy, Treatment, University of Leeds.This article was ...
Subject: University of Leeds
Price: $3.00
*
Scientists at Semmelweis University, Medical Department publish new data on molecular pharmaceutics
2009 NOV 25 ... Life Sciences, Molecular Pharmacology, Molecular Therapies, Therapy, Treatment, Drug Development, Metabolism, Pharmaceuticals, Molecular Pharmaceutics, Semmelweis University, Medical ...
Subject: Molecular Pharmaceutics
Price: $3.00
*
Scripps team shows diet switching can activate brain's stress system, lead to 'withdrawal' symptoms
2009 NOV 29 ... stop eating their regular food, and show withdrawal-like behaviors often associated with drug addiction. As in addiction to drugs or ethanol, the brain's stress system is involved ... itself," said Cottone.In addition, the research opens the door to potential development of a drug therapy to assist people escape an unhealthy cycle of ...
Subject: Scripps Research Institute
Price: $3.00
*
Why can't chimps speak?
2009 NOV 29 ... process language.Keywords: Psychiatry, Autism, Developmental Disabilities, Drug Development, Neurology, Psychiatry, Schizophrenia, Speech, Therapy, Treatment, University of ...
Subject: University of California - Los Angeles
View Free
Daily News
Article

Results 1 - 20      Next >




-----------------------
PR Login